Double-blind clinical evaluation of the efficacy and safety of ergostine-caffeine, ergotamine-caffeine, and placebo in migraine headache.

• Authors: R E Ryan
• Journal: Headache (Headache) Vol. 9 Issue 4 Pg. 212-20 (Jan 1970) ISSN: 0017-8748 [Print] United States
• PMID: 4904954 (Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article)

Chemical References

• Ergot Alkaloids
• Placebos
• Caffeine
• Ergotamine

Topics

• Adolescent
• Adult
• Aged
• Caffeine (therapeutic use)
• Clinical Trials as Topic
• Ergot Alkaloids (therapeutic use)
• Ergotamine (therapeutic use)
• Female
• Headache (drug therapy)
• Humans
• Male
• Middle Aged
• Migraine Disorders (drug therapy)
• Placebos (therapeutic use)